SCHEMBL3205000

SCHEMBL3205000

CCCCCCCCCC=CCCCCCCCC(=O)NOC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.68
TRPV1 Q8NER1 1/20 0.68
FAAH O00519 4/20 0.62
CYP1A2 P05177 2/20 0.62
CYP2C19 P33261 2/20 0.62
KMT2A Q03164 2/20 0.62
MEN1 O00255 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62
SOAT1 P35610 1/20 0.62
SLC6A5 Q9Y345 2/20 0.59
HRH3 Q9Y5N1 1/20 0.58
TERT O14746 3/20 0.58
PTPN1 P18031 3/20 0.58
PPARG P37231 3/20 0.58
PPARD Q03181 3/20 0.58
PPARA Q07869 3/20 0.58
MAPT P10636 2/20 0.58
BLM P54132 2/20 0.58
HSD17B10 Q99714 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188942 0.93 CNR2 (0.59) CNR2TRPV1FAAHCYP1A2CYP2C19
SCHEMBL4016383 0.89 HSP90AA1 (0.59) CNR2TRPV1FAAHKMT2AMEN1
SCHEMBL6926300 0.89 HSP90AA1 (0.59) CNR2TRPV1FAAHKMT2AMEN1
SCHEMBL5792516 0.89 HSP90AA1 (0.59) CNR2TRPV1FAAHKMT2AMEN1
SCHEMBL6924837 0.89 HSP90AA1 (0.59) CNR2TRPV1FAAHKMT2AMEN1
SCHEMBL29539532 0.88 CNR2 (0.69) CNR2TRPV1FAAHCYP1A2CYP2C19
SCHEMBL19812439 0.88 CNR2 (0.69) CNR2TRPV1FAAHCYP1A2CYP2C19
SCHEMBL19812449 0.88 CNR2 (0.69) CNR2TRPV1FAAHCYP1A2CYP2C19
SCHEMBL13479772 0.87 HSP90AA1 (0.56) CNR2TRPV1FAAHKMT2AMEN1
SCHEMBL8496765 0.85 CNR2 (0.75) CNR2TRPV1FAAHCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662971-B2 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2010-02-16 US disclosed
EP-2093220-A2 Inhibitors of fatty acid amide hydrolase The Scripps Research Institute (US) 2009-08-26 EP disclosed
EP-1549624-B1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2009-05-13 EP disclosed
US-20060111359-A1 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2006-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111359-A1 enzyme inhibitor for treating sleep disorders FAAH, FAAH2, HCRTR2 CNR2 4/4885TRPV1 664/4885FAAH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.